Koninklijke Philips (PHG) FCF Margin (2009 - 2026)
Koninklijke Philips' (PHG) quarterly FCF Margin came in at 6.68% in Q1 2026, up 2811.0% year-on-year from 0.23% in Q1 2025, and down 79.48% quarter-over-quarter from 32.57% in Q4 2025.
Koninklijke Philips (PHG) FCF Margin (2009 - 2026) Analysis & Trends
Koninklijke Philips' FCF Margin history runs 18 years deep, the most recent figure standing at 6.68% for Q1 2026.
- On a quarterly basis, FCF Margin rose 2811.0% year-over-year to 6.68% in Q1 2026; TTM through Mar 2026 was 16.68%, a 829.0% increase from a year earlier, with the FY2025 full-year figure at 5.06%, down 188.0% from the prior year.
- FCF Margin slipped to 6.68% in Q1 2026 per PHG's latest filing, from 32.57% in the prior quarter.
- Across five years, FCF Margin topped out at 35.21% in Q4 2024 and bottomed at 21.43% in Q1 2025.
- The 5-year median for FCF Margin is 6.68% (2026), against an average of 8.5%.
- Across the five-year window, FCF Margin sank 1928 bps in 2025 and jumped 2811 bps in 2026, its largest moves.
- Year by year, FCF Margin stood at 5.0% in 2022, then jumped by 554 bps to 32.69% in 2023, then grew by 8 bps to 35.21% in 2024, then decreased by 8 bps to 32.57% in 2025, then tumbled by 79 bps to 6.68% in 2026.
- Per Business Quant, the three latest PHG FCF Margin figures stand at 6.68% (Q1 2026), 32.57% (Q4 2025), and 11.92% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 15.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.68% |
| Dec 31, 2025 | 32.57% |
| Sep 30, 2025 | 11.92% |
| Jun 30, 2025 | 11.64% |
| Mar 31, 2025 | -21.43% |
| Dec 31, 2024 | 35.21% |
| Sep 30, 2024 | 9.73% |
| Jun 30, 2024 | 3.70% |
| Mar 31, 2024 | -2.15% |
| Dec 31, 2023 | 32.69% |
| Sep 30, 2023 | 14.43% |
| Jun 30, 2023 | 5.95% |
| Mar 31, 2023 | 6.89% |
| Dec 31, 2022 | 5.00% |
| Sep 30, 2022 | -2.09% |
| Jun 30, 2022 | -2.78% |
| Mar 31, 2022 | -3.45% |
| Dec 31, 2021 | 22.59% |
| Sep 30, 2021 | 8.85% |
| Jun 30, 2021 | 11.51% |